Related Experiment Video
Updated: Jan 26, 2026

Selective Capture of 5-hydroxymethylcytosine from Genomic DNA
Published on: October 5, 2012
Gold nanoparticles loaded with cullin-5 DNA increase sensitivity to 17-AAG in cullin-5 deficient breast cancer cells
Sarah Talamantez-Lyburn1, Pierce Brown2, Nicole Hondrogiannis2
1Department of Biological Sciences, Towson University, Towson, MD, United States.
Abstract:
HSP90 inhibitors have the potential to treat many types of cancer due to the dependence of tumor cells on HSP90 for cell growth and proliferation. The Cullin-5 (Cul5) E3 ubiquitin ligase is required for HSP90 inhibitors to induce client protein degradation and subsequent cell death. Cul5 is expressed at low levels in breast cancer cells compared to patient matched controls. This observed low Cul5 expression may play a role in the reported decreased efficacy of 17-AAG and related HSP90 inhibitors as a monotherapy. We have developed a method for delivery of 17-AAG plus Cul5 DNA to cells via gold nanoparticles (AuNPs). Delivery of AuNPs containing Cul5 DNA increases the sensitivity of Cul5 deficient AU565 cells to 17-AAG. Characterization of AuNPs by UV-vis spectrum, TEM, gel electrophoresis assay and 1H NMR indicate attachment of both 17-AAG and DNA payload as well as AuNP stability. Studies in Cul5 deficient AU565 cells reveal that delivery of Cul5 and 17-AAG together increase cytotoxicity. Our results provide evidence that delivery of DNA with drug may serve as a method to sensitize drug resistant tumor cells.
Insights
Gold nanoparticles deliver Heat Shock Protein 90 (HSP90) inhibitor 17-AAG and Cullin-5 (Cul5) DNA to cancer cells. This combination therapy overcomes drug resistance in Cul5-deficient breast cancer cells.
Area of Science:
- Oncology
- Nanotechnology
- Molecular Biology
Background:
- Heat Shock Protein 90 (HSP90) inhibitors show promise for cancer treatment due to tumor cell dependence on HSP90.
- Cullin-5 (Cul5) E3 ubiquitin ligase is crucial for HSP90 inhibitor efficacy, but its low expression in breast cancer may limit treatment success.
- The decreased efficacy of HSP90 inhibitors like 17-AAG as monotherapy in some breast cancers is potentially linked to low Cul5 levels.
Purpose of the Study:
- To investigate the role of Cullin-5 (Cul5) expression in breast cancer's response to HSP90 inhibitors.
- To develop a novel drug delivery system using gold nanoparticles (AuNPs) for combined delivery of 17-AAG and Cul5 DNA.
- To evaluate the efficacy of this combined delivery system in sensitizing Cul5-deficient breast cancer cells to 17-AAG.
Main Methods:
- Gold nanoparticles (AuNPs) were synthesized and characterized using UV-vis spectroscopy, Transmission Electron Microscopy (TEM), gel electrophoresis, and 1H NMR.
- AuNPs were loaded with both the HSP90 inhibitor 17-AAG and Cul5 DNA.
- Cul5-deficient AU565 breast cancer cells were treated with AuNPs carrying 17-AAG and Cul5 DNA, and cytotoxicity was assessed.
Main Results:
- Characterization confirmed successful attachment of 17-AAG and DNA to AuNPs, along with AuNP stability.
- Delivery of AuNPs containing Cul5 DNA significantly increased the sensitivity of Cul5-deficient AU565 cells to 17-AAG.
- Combined delivery of Cul5 DNA and 17-AAG via AuNPs resulted in enhanced cytotoxicity in AU565 cells.
Conclusions:
- Low Cullin-5 (Cul5) expression may contribute to resistance against HSP90 inhibitors in breast cancer.
- Gold nanoparticle-mediated co-delivery of Cul5 DNA and 17-AAG is a viable strategy to enhance anti-cancer efficacy.
- This approach offers a potential method to sensitize drug-resistant tumor cells, improving therapeutic outcomes for HSP90 inhibitor treatments.
Related Concept Videos
5-Number Summary
In a box plot, the minimum and maximum data values represent the lower and upper whiskers in the graph, and the median is designated as the center of the box in the chart. The first quartile and third...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
DNA-only Transposons
The donor site from where the transposon is excised is either degraded or...
Increased Body Temperature
Increased pulse rate
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
DNA Replication
Replication in Prokaryotes
DNA replication...

